Livi McKay shares how she's using tech and science to identify cannabis's therapeutic effects so users get the true medicinal experience needed.
SHARE
90
12
Featuring Livi McKay and Tony Greer
Oct 06, 2021 • 36 minutes
After the devastating Tuscaloosa tornados of 2011, Livi McKay lost everything and was left with debilitating health issues that traditional medicine could not effectively treat—until she started using cannabis. She joins Tony Greer of TG Macro to share her story from growing up in a conservative family in Alabama, where cannabis was highly illegal, to becoming the founder and CEO of MyTEPI in Nevada. She explains how she’s using plant-based pharmacology to equip dispensaries with science-backed knowledge of cannabis’s therapeutic effects for the benefit of end users. McKay also discusses how her vision for the future of healthcare coincides with other ongoing developments in the medical industry such as psychedelic therapy and DNA sequencing. Filmed on September 27, 2021.
Show MoreEver-inquisitive trader Tony Greer sits down with some of the investing world's most colorful personalities to talk about where they've been and where they're going. Greer's natural curiosity often guides guests to uncharted territory, leading to fresh observations and keen insights for all of us. He specializes in probing the career-making moves that have shaped his guests' perspectives.
More EpisodesThis content is reserved for the thousands of visionaries supporting the financial revolution. We'd love for you to join us. Interested?
See Our PlansAlready have an account? Log In
Ever-inquisitive trader Tony Greer sits down with some of the investing world's most colorful personalities to talk about where they've been and where they're going. Greer's natural curiosity often guides guests to uncharted territory, leading to fresh observations and keen insights for all of us. He specializes in probing the career-making moves that have shaped his guests' perspectives.
More Episodes
COMMENTS
Sort ByAccess Essential Content
This content is reserved for the thousands of visionaries supporting the financial revolution. We'd love for you to join us. Interested?
See Our PlansAlready have an account? Log In